Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.12%71.97B | -5.68%296.05B | -6.89%74.29B | 1.94%313.88B | -4.62%75.51B | -2.54%81.72B | -1.15%76.86B | 18.85%79.78B | 26.61%307.91B | 30.97%79.17B |
| Cost of revenue | -3.57%64.11B | -6.70%264.17B | -9.05%66.48B | -0.72%283.15B | -8.79%66.79B | -5.23%73.55B | -1.52%69.72B | 14.96%73.1B | 29.36%285.22B | 31.73%73.23B |
| Gross profit | 0.73%7.86B | 3.75%31.87B | 16.84%7.8B | 35.38%30.72B | 46.78%8.72B | 30.87%8.18B | 2.63%7.15B | 88.57%6.68B | -0.08%22.69B | 22.29%5.94B |
| Operating expense | -1.87%6.39B | 11.14%25.53B | 18.46%6.51B | 8.00%22.97B | 14.41%6.03B | 10.48%5.96B | 2.37%5.49B | 4.77%5.49B | 15.48%21.27B | 13.44%5.27B |
| Operating profit | 13.80%1.48B | -18.14%6.34B | 9.36%1.3B | 444.55%7.75B | 302.70%2.69B | 159.53%2.22B | 3.50%1.66B | 169.72%1.19B | -66.86%1.42B | 219.14%667M |
| Net non-operating interest income (expenses) | -51.35%-56M | -5.14%-184M | 19.57%-37M | -18.24%-175M | 14.29%-42M | -7.32%-44M | -22.86%-43M | -100.00%-46M | -85.00%-148M | -308.33%-49M |
| Non-operating interest income | --0 | -25.00%6M | --0 | -20.00%8M | -50.00%1M | -33.33%2M | 50.00%3M | -33.33%2M | -28.57%10M | -33.33%2M |
| Non-operating interest expense | 51.35%56M | 3.83%190M | -22.92%37M | 15.82%183M | -15.69%43M | 4.55%46M | 24.32%46M | 84.62%48M | 68.09%158M | 240.00%51M |
| Net investment income | 11.21%129M | 5.13%164M | 4.50%116M | 7.59%156M | 0 | 7.32%44M | -50.00%1M | 8.82%111M | 5.07%145M | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -103.92%-8M | 0 | -33.11%204M | 30.69%132M | -63.73%74M | 0 | -2M | 609.30%305M | 5,150.00%101M | |
| Income from associates and other participating interests | 101.40%288M | 141.35%129M | 21.19%143M | -642.86%-312M | -86.57%-125M | -1,764.71%-317M | 157.14%12M | 87.30%118M | -138.53%-42M | -844.44%-67M |
| Special income (charges) | -70.99%47M | 98.80%-5M | 209.46%162M | -10.08%-415M | 9.52%-152M | 48.88%-91M | 25.00%-24M | -14,900.00%-148M | -1,884.21%-377M | -663.64%-168M |
| Less:Restructuring and mergern&acquisition | --0 | 6.04%158M | -225.87%-180M | -29.38%149M | -98.10%4M | --1M | --1M | --143M | --211M | --211M |
| Less:Other special charges | -361.11%-47M | -488.71%-241M | 260.00%18M | 247.62%62M | 188.37%38M | 300.00%2M | -32.00%17M | 121.74%5M | 66.13%-42M | -295.45%-43M |
| Less:Write off | ---- | -56.86%88M | ---- | -1.92%204M | --110M | -50.84%88M | -14.29%6M | --0 | 45.45%208M | --0 |
| Other non-operating income (expenses) | -76.70%24M | 5.00%336M | 18.39%103M | -3.90%320M | -40.98%72M | -23.71%74M | 180.65%87M | 4.82%87M | -44.87%333M | 27.08%122M |
| Income before tax | 7.07%1.91B | -9.97%6.77B | 36.73%1.78B | 359.06%7.52B | 325.33%2.57B | 103.22%1.96B | 9.51%1.69B | 188.47%1.3B | -67.80%1.64B | 115.71%604M |
| Income tax | -41.03%263M | -46.68%1.29B | 19.25%446M | 304.36%2.41B | 243.78%746M | 132.33%697M | 3.31%593M | 175.56%374M | -57.46%596M | 444.44%217M |
| Net income | 23.04%1.65B | 7.33%5.49B | 43.92%1.34B | 390.69%5.11B | 372.28%1.82B | 90.06%1.26B | 13.30%1.1B | 194.99%929M | -71.75%1.04B | 12.21%386M |
| Net income continuous operations | 23.11%1.65B | 7.33%5.49B | 43.76%1.34B | 390.32%5.11B | 371.06%1.82B | 90.06%1.26B | 13.18%1.1B | 194.99%930M | -71.73%1.04B | 12.83%387M |
| Noncontrolling interests | -78.13%7M | 248.28%101M | 300.00%32M | 141.67%29M | 57.14%-3M | -500.00%-6M | 114.29%30M | 33.33%8M | -58.62%12M | 0.00%-7M |
| Net income attributable to the company | 25.54%1.64B | 5.96%5.39B | 41.59%1.3B | 393.59%5.08B | 363.71%1.83B | 90.68%1.27B | 11.83%1.07B | 193.60%921M | -71.85%1.03B | 12.57%394M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 25.54%1.64B | 5.96%5.39B | 41.59%1.3B | 393.59%5.08B | 363.71%1.83B | 90.68%1.27B | 11.83%1.07B | 193.60%921M | -71.85%1.03B | 12.57%394M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 25.70%42.85 | 5.92%140.84 | 41.33%34.09 | 392.30%132.97 | 362.69%47.75 | 89.75%33.15 | 11.71%27.95 | 193.49%24.12 | -71.46%27.01 | 9.79%10.32 |
| Diluted earnings per share | 25.70%42.85 | 5.92%140.84 | 41.33%34.09 | 392.30%132.97 | 362.68%47.7469 | 90.10%33.1375 | 11.71%27.95 | 193.49%24.12 | -71.46%27.01 | 12.48%10.3196 |
| Dividend per share | 0 | 31.48%35.5 | 0 | 8.00%27 | 16.00%14.5 | 0 | 0.00%12.5 | 0 | 0.00%25 | 0.00%12.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |